Giglia Matthew D, Chu Daniel I
Division of Gastrointestinal Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Clin Colon Rectal Surg. 2016 Sep;29(3):185-95. doi: 10.1055/s-0036-1584290.
While most colorectal cancers (CRCs) originate from nonhereditary spontaneous mutations, one-third of cases are familial or hereditary. Hereditary CRCs, which account for < 5% of all CRCs, have identifiable germline mutations and phenotypes, such as Lynch syndrome and familial adenomatous polyposis (FAP). Familial CRCs, which account for up to 30% of CRCs, have no identifiable germline mutation or specific pattern of inheritance, but higher-than-expected incidence within a family. Since the discovery that certain genotypes can lead to development of CRC, thousands of mutations have now been implicated in CRC. These new findings have enhanced our ability to identify at-risk patients, initiate better surveillance, and take preventative measures. Given the large number of genes now associated with hereditary and familial CRCs, clinicians should be familiar with the alphabet soup of genes to provide the highest quality of care for patients and families.
虽然大多数结直肠癌(CRC)起源于非遗传性自发突变,但三分之一的病例是家族性或遗传性的。遗传性结直肠癌占所有结直肠癌的比例不到5%,具有可识别的种系突变和表型,如林奇综合征和家族性腺瘤性息肉病(FAP)。家族性结直肠癌占结直肠癌的比例高达30%,没有可识别的种系突变或特定的遗传模式,但在一个家族中的发病率高于预期。自从发现某些基因型可导致结直肠癌的发生以来,现在已有数千种突变与结直肠癌有关。这些新发现提高了我们识别高危患者、开展更好的监测以及采取预防措施的能力。鉴于现在有大量基因与遗传性和家族性结直肠癌相关,临床医生应该熟悉这些纷繁复杂的基因,以便为患者及其家庭提供最高质量的护理。